Digoxin and mortality in patients with atrial fibrillation

RD Lopes, R Rordorf, GM De Ferrari, S Leonardi… - Journal of the American …, 2018 - jacc.org
Background: Digoxin is widely used in patients with atrial fibrillation (AF). Objectives: The
goal of this paper was to explore whether digoxin use was independently associated with …

Meta-analysis of effects of digoxin on survival in patients with atrial fibrillation or heart failure: an update

M Vamos, JW Erath, AP Benz, RD Lopes… - The American journal of …, 2019 - Elsevier
In 2015, 3 independent meta-analyses raised concerns about digoxin therapy being
associated with an increased mortality risk in patients with atrial fibrillation (AF) and with …

Effect of digoxin therapy on mortality in patients with atrial fibrillation: an updated meta-analysis

X Wang, Y Luo, D Xu, K Zhao - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Background: Whether digoxin is associated with increased mortality in atrial fibrillation (AF)
remains controversial. We aimed to assess the risk of mortality and clinical effects of digoxin …

[PDF][PDF] Phytochemical screening of Phyllanthus niruri collected from Kerala region and its antioxidant and antimicrobial potentials

K Ramandeep, A Nahid, C Neelabh… - … Sciences and Research, 2017 - researchgate.net
Various compounds found in the plant have shown antioxidant and antimicrobial activity. In
this study, the phytochemical screening, antioxidant and antimicrobial activity of Phyllanthus …

Association between digoxin use and adverse outcomes among patients in the Chinese atrial fibrillation registry

Y Gao, S Chang, X Du, J Dong, X Xu, Y Zhou… - American Journal of …, 2019 - Springer
Introduction Digoxin is widely used in patients with atrial fibrillation (AF), but its association
with adverse outcomes remains controversial. Objective We aimed to assess the association …

Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews

WL Baker, DM Sobieraj… - … : The Journal of Human …, 2021 - Wiley Online Library
Once a routine part of atrial fibrillation (AF) management, digoxin use has declined. Likely
hastening this decline are findings from several studies and systematic reviews identifying a …

Роль ЧСС в механизмах компенсации и декомпенсации у бльных с ХСН при синусовом ритме и фибрилляции предсердий и методы безопасного и …

ВЮ Мареев, ЮВ Мареев - Кардиология, 2017 - lib.ossn.ru
Роль ЧСС в механизмах компенсации и декомпенсации у бльных с ХСН при синусовом
ритме и фибрилляции предсердий и методы безопасного и эффективного контроля …

[PDF][PDF] Mortada Mohammed Hameed

A Najm - medicine.uodiyala.edu.iq
Background: Digoxin is recommended for long-term rate control in paroxysmal, persistent,
and permanent atrial fibrillation (AF). While some analyses suggest an association of …

Mortalidade associada ao uso da digoxina no tratamento da fibrilação atrial: uma revisão integrativa

KVAR Ramos, VA da Nóbrega, GA Vilela… - Research, Society and …, 2021 - rsdjournal.org
Atrial fibrillation (AF) is the most prevalent arrhythmia, triggering an irregular and fast heart
rhythm. Although it is not always the drug of first choice, digoxin is still widely used, although …

[HTML][HTML] Analyzing gender and racial effects of digoxin vs diltiazem in atrial fibrillation mortality using large EHR data

SR Sathyanarayanan, M Sutton - Oklahoma State …, 2019 - okstatemedicalproceedings.com
Digoxin is an atrial fibrillation (AF) rate control drug that is still in use. New randomized trial
data comparing digoxin with other agents is unlikely to become available, but observational …